# Fixed Dose Combination Drug (Polypill)for Secondary Cardiovascular Prevention.

Study · id `cardio:ct-nct01321255` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01321255](<https://clinicaltrials.gov/study/NCT01321255>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01321255

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2118 participants.

## Technical summary

Registry record NCT01321255. Randomized; no masking; primary purpose prevention. Start 2012-01 (registry gives no type); primary completion 2014-05 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Phase 3
- Enrolled: 2118 participants (enrolled count; ClinicalTrials.gov record NCT01321255, source copy `cardio:ctgov-nct01321255-2014-07-15`, retrieved 2026-10-26)
- Start date: 2012-01 (registry gives no type) (ClinicalTrials.gov record NCT01321255, source copy `cardio:ctgov-nct01321255-2014-07-15`, retrieved 2026-10-26)
- Primary completion: 2014-05 (actual) (ClinicalTrials.gov record NCT01321255, source copy `cardio:ctgov-nct01321255-2014-07-15`, retrieved 2026-10-26)
- Completion: 2014-06 (actual) (ClinicalTrials.gov record NCT01321255, source copy `cardio:ctgov-nct01321255-2014-07-15`, retrieved 2026-10-26)
- Countries: Argentina; Brazil; Italy; Paraguay; Spain (ClinicalTrials.gov record NCT01321255, source copy `cardio:ctgov-nct01321255-2014-07-15`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01321255-2014-07-15`, retrieved 2026-10-26)

## The registry's words

- Brief title: Fixed Dose Combination Drug (Polypill)for Secondary Cardiovascular Prevention.
- Acronym: FOCUS
- Condition: Myocardial Infarction
- Intervention (Drug): FDC
- Intervention (Drug): Separately drugs, simvastatin, aspirin and ramipril
- Lead sponsor: Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III
- Lead sponsor class: OTHER
- Collaborator: Mario Negri Institute for Pharmacological Research
- Collaborator class: OTHER
- Collaborator: Rusculleda Foundation Instituto DAMIC
- Collaborator class: UNKNOWN
- Collaborator: Fundacion Clinic per a la Recerca Biomédica
- Collaborator class: OTHER
- Collaborator: ARTTIC International Management Services
- Collaborator class: UNKNOWN
- Collaborator: Federación Argentina de Cardiología FAC
- Collaborator class: UNKNOWN
- Collaborator: World Health Organization
- Collaborator class: OTHER
- Collaborator: Instituto de Salud Carlos III
- Collaborator class: OTHER\_GOV
- Collaborator: Ferrer Internacional S.A.
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry lists this organization as the lead sponsor: Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III (`cardio:org-fundacion-centro-nacional-de-investigaciones-0f9f16`)
- Registry lists this organization as a collaborator: Mario Negri Institute for Pharmacological Research (`cardio:org-mario-negri-institute-for-pharmacological-research`)
- Registry lists this organization as a collaborator: World Health Organization (`cardio:who`)
- Registry lists this organization as a collaborator: Instituto de Salud Carlos III (`cardio:org-instituto-de-salud-carlos-iii`)
- Registry lists this organization as a collaborator: Ferrer Internacional S.A. (`cardio:org-ferrer-internacional-s-a`)

## Provenance

Content hash: 67c9d6094806a41aad279784568ce2926511bb8c328efc2b12b4129b634e2269
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
